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Background: The population aged 85 + − the “oldest old” – is now the fastest growing age segment in Canada.
Although existing research demonstrates high health services utilization and medication burden in this population,
little clinically derived evidence is available to guide care. This is a descriptive study in a primary care context
seeking to describe the most common health conditions and medications used in the “oldest old”.
Methods: We conducted a retrospective chart review of all family practice patients aged 85+ (N = 564; 209 males,
355 females) at Sunnybrook Health Sciences Centre in Toronto, Canada. Electronic medical records were reviewed
for all current chronic conditions and medication prescriptions, and then stratified by sex and age subgroup
(85–89, 90–94, 95+) for descriptive analysis.
Results: On average, patients experienced 6.4 concurrent chronic conditions and took 6.8 medications. Most
conditions were related to cardiovascular (79%) and bone health (65%). Hypertension (65%) was the most
common condition. Bone-related conditions (e.g. osteoarthritis, osteoporosis) and hypothyroidism predominantly
affected women, while coronary artery disease and type 2 diabetes were more prevalent in men. The top two
prescribed medications were atorvastatin (33%) and aspirin 81 mg (33%). Males were more likely to be prescribed
lipid-lowering medications, while females were more likely to receive osteoporosis therapy. Patients received less
lipid-lowering therapy with increasing age.
Conclusions: Multimorbidity and polypharmacy are highly prevalent in patients in the 85+ age group. The most
common clinical conditions are related to cardiovascular and bone health, and the most commonly prescribed
medications are directed towards risk factors for these illnesses. In the absence of data to guide clinical
decision-making, this study provides a first look at the common health concerns and medication profiles in this
population and reveals trends that give rise to reflections on how clinical care for these patients can be improved.
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The Canadian population is rapidly aging, with patients
aged 85 + − the “oldest old” – now representing one of the
fastest growing age segments in the country [1]. Compared
to their 65-to-74-year-old counterparts, these patients have
more chronic health conditions [2], use more health* Correspondence: tsoi.cs@gmail.com
4Department of Family Medicine, Mount Sinai Hospital, Toronto M5T 3 L9,
ON, Canada
6Mount Sinai Hospital Sherman Health and Wellness Centre, 9600 Bathurst
Street, Suite 300, Vaughan L6A3Z8, ON, Canada
Full list of author information is available at the end of the article
© 2014 Tsoi et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the orservices [3] and have seen a dramatic rise in medication
prescriptions [4]. Increased consumption of health services
and polypharmacy are trends reflected in the concept of
“multimorbidity”, which despite conflicting definitions is
unequivocally more prevalent in patients aged 85+ than in
any other age segment [5-7].
Much of the health care burden for this patient group
falls on primary care providers [8]. As these providers seek
to provide patient-centered and evidence-based care for
this population, a major challenge lies in the lack of data
describing even basic clinical characteristics of these. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Table 1 Demographic profile of family practice patients
aged 85+ at Sunnybrook Health Sciences Centre
85-89 yrs 90-94 yrs 95+ yrs Total
Sex
Female 219 (61) 113 (65) 23 (72) 355 (63)
Male 140 (39) 60 (35) 9 (28) 209 (37)
Total 359 (100) 173 (100) 32 (100) 564 (100)
Values are numbers (percentages) of patients.
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the present study is to determine the most prevalent
health conditions and prescription medications among pa-
tients aged 85+ in an academic family practice setting. We
will also describe the clinical complexity of these patients
by using the “complexity score” [9] – a clinical tool to
measure the extent of multimorbidity in the elderly. Our
data reveals trends which give rise to reflections on how
clinical care of the oldest old patients can be improved.
Methods
Ethics statement
Ethics approval was obtained prior to this study from the
Sunnybrook Health Sciences Centre Research Ethics Office.
This office specifically waived the requirement for written
consent by the patients whose charts were reviewed.
Study design
We conducted a retrospective chart review for all patients
aged 85+ in the Family Practice Unit (FPU) at Sunnybrook
Health Sciences Centre in Toronto, Canada.
Setting and study population
The Sunnybrook FPU is an academic primary care prac-
tice fully-affiliated with the University of Toronto. The
clinic has 13 staff family physicians that belong to an FPU
team which also comprises medical trainees, nurses, social
workers, dietitians and diabetes educators. The FPU pro-
vides care to approximately 8,500 patients, with a focus on
older patients with complex chronic disease. All patients
who were 85 years of age or older as of January 1, 2011
and had complete medical records (current chronic health
conditions and prescribed medications) were included in
this study (N = 564; 209 males and 355 females).
Data collection
The electronic medical record of each eligible patient was
reviewed and data was extracted from their Cumulative
Patient Profile (CPP). The CPP is a section included in all
Canadian electronic medical record systems [10] which
allows family physicians to upkeep a patient’s information
in a compact fashion, including his or her current chronic
conditions and medications. However, the information is
not standardized. We used an automated script to abstract
each patient’s current chronic conditions and medication
lists (CT) and manually reviewed the data for consistency
and duplications (KC). Past medical history that was
chronic in nature (e.g. hypertension, osteoarthritis) was
counted as a current chronic condition.
Analysis
Patients were grouped by sex and by 5-year age intervals
(i.e. 85–89, 90–94, 95+) as determined by their age on
January 1, 2011. Descriptive statistics for chronic illnessesand medications were calculated by sex and age group.
For each patient, the “complexity score” was calculated by
summing the number of long-term medications and the
number of current chronic conditions. For example, a pa-
tient with five chronic conditions and three medications
would be assigned a “complexity score” of eight. The
“complexity score” is a measure that has been shown to
have strong positive association with hospitalizations,
emergency room visits, and family physician visits [9].
Patients were categorized by their complexity score into
sextiles (i.e. 0–5, 6–10, 11–15, 16–20, 21–25, >25), and
the distribution was studied against age and sex.Results
Table 1 shows the demographics of the study population
by age group and sex. Overall, there were more females
(63%) than males (37%). This difference in the distribution
of sex widened with increasing age. The total number of
patients in this study comprised 6.4% of the 8767 total
patients in the family practice.
Table 2 presents data on the 10 most common medical
conditions in our study sample overall and by sex. Over-
all, patients in our study sample experienced 6.4 chronic
medical conditions (data not shown). Four of the 10 most
common diseases were cardiovascular risk factors (hyper-
tension, dyslipidemia, atrial fibrillation, type 2 diabetes)
with hypertension the most common, prevalent in appro-
ximately 65% of the study population. Both males
and females shared these 4 conditions in their top 10
list, along with non-cardiovascular conditions such as
osteoarthritis and hearing loss. In our sample, osteopor-
osis, hypothyroidism, and gastro-esophageal reflux disease
(GERD) were more common in females. Among males,
coronary artery disease (16.3%) was more prevalent.
Table 3 presents the top 10 most common diseases by
age group. Across age groups it is apparent that the pre-
valence of hypertension, osteoarthritis, and osteoporosis
increased with age. Conversely, dyslipidemia, diabetes, and
coronary artery disease decreased in prevalence with ad-
vancing age and were not among the 10 most common
conditions in the highest age bracket.
Tables 4 and 5 present, respectively, the top 10 most
common prescription medications and medication classes
Table 2 Top 10 most common chronic conditions in patients aged 85+ by sex
Males Females Overall
Rank Disease % Disease % Disease %
1 Hypertension 61.7 Hypertension 66.8 Hypertension 64.9
2 Benign prostate hypertrophy 28.7 Osteoporosis 49.6 Osteoarthritis 37.1
3 Dyslipidemia 28.2 Osteoarthritis 42.5 Osteoporosis 35.8
4 Osteoarthritis 27.8 Dyslipidemia 23.4 Dyslipidemia 25.2
5 Atrial fibrillation 27.3 Hypothyroidism 21.7 Atrial fibrillation 22.7
6 Type 2 diabetes 22.0 Atrial fibrillation 20.0 Hypothyroidism 17.7
7 Chronic renal failure 18.2 Osteopenia 17.5 Type 2 diabetes 17.2
8 Hearing loss 16.8 Type 2 diabetes 14.4 Hearing loss 15.1
9 Coronary artery disease 16.3 GERD 14.4 Osteopenia 13.5
10 Glaucoma 14.4 Hearing loss 14.1 Glaucoma 13.3
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age of 6.8 medications (data not shown). The range was 0
to 18 and the interquartile range was 5 to 9. Only 3 of the
top 10 medication classes overall were meant for symptom
relief, and these have been bolded in Table 5. The re-
maining 7 classes were prescribed for risk factor modifica-
tion, including 4 for cardiovascular disease alone. Overall,
88.7% of patients were taking some type of cardiovascular
medication. 207 out of the 337 patients (61.4%) who had
been prescribed either aspirin, a statin, or both medica-
tions did not have a diagnosis of either coronary artery
disease or Type 2 diabetes charted in their CPP (data not
shown). There were no medications for glycemic control
in the top 10 list for any gender or age group.
Tables 6 and 7 present, respectively, the top 10
most common prescription medications and medication
classes by age group. Across age groups, we found
that the rate of statin use declined with advancing
age and the use of acetaminophen rose. There was a
decline in the number of different medications for car-
diovascular risk factors (particularly hypertension) with
increasing age.Table 3 Top 10 most common chronic conditions by age grou
85-89 yrs 90-94
Rank Disease % Disea
1 Hypertension 63.2 Hyper
2 Osteoarthritis 35.4 Osteo
3 Osteoporosis 32.0 Osteo
4 Dyslipidemia 27.6 Hypot
5 Atrial fibrillation 23.1 Dyslip
6 Type 2 diabetes 18.9 Atrial
7 Hypothyroidism 15.0 Hearin
8 Osteopenia 13.7 Glauco
9 Degenerative disc disease 13.4 Type 2
10 Coronary artery disease 12.5 OsteoThe complexity scores followed a mildly skewed right
normal distribution across age and sex categories. The
mean and median complexity scores in our sample were
13.3 and 12.5, respectively. The range was 2 to 29. We did
not observe any significant differences between categories.
Approximately one-third of our sample (35%; n = 198)
had a complexity score between 11–15.
Discussion
This large study of community-dwelling seniors over the
age of 85 demonstrates that this population is afflicted
by a large number of common chronic diseases and
takes a large number of medications. Hypertension, osteo-
arthritis, dyslipidemia, atrial fibrillation, type 2 diabetes
and hearing loss are highly prevalent in both sexes. Other
conditions show variance between genders, suggesting
that patterns noted in younger age groups such as females
with hypothyroidism [11] and males with coronary artery
disease [12] persist into older age.
The study of disease prevalence between age brackets
in our data set also reveals insights that are relevant
to the clinical care of younger seniors. Specifically, therep
yrs 95+ yrs
se % Disease %
tension 67.1 Hypertension 71.9
arthritis 38.7 Osteoporosis 65.6
porosis 38.2 Osteoarthritis 46.9
hyroidism 24.3 Atrial fibrillation 31.3
idemia 22.5 GERD 25.0
fibrillation 20.2 Dementia (all types) 21.9
g loss 19.1 Hearing loss 21.9
ma 16.2 Hiatus hernia 18.8
diabetes 15.6 Depression 15.6
penia 13.9 Anemia 12.5
Table 4 Top 10 most common prescription medications in patients aged 85+ by sex
Males Females Overall
Rank Medication % Medication % Medication %
1 Atorvastatin 40.7 ASA (mini) 31.8 Atorvastatin 32.8
2 ASA (mini) 34.0 Atorvastatin 28.2 ASA (mini) 32.6
3 Ramipril 34.0 Hydrochlorothiazide 28.2 Hydrochlorothiazide 28.2
4 Hydrochlorothiazide 28.2 Levothyroxine 26.8 Ramipril 25.7
5 Metoprolol 26.3 Vitamin D 26.2 Amlodipine 23.8
6 Warfarin 24.9 Amlodipine 25.4 Vitamin D 23.4
7 Docusate 23.4 Alendronate 23.7 Levothyroxine 23.2
8 Amlodipine 21.1 Ramipril 20.9 Warfarin 20.7
9 Nitroglycerin spray 19.6 Acetaminophen 20.9 Docusate 20.6
10 Vitamin D 18.7 Calcium 20.9 Metoprolol 19.0
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lipidemia, diabetes, and coronary artery disease in that
the patients who survived the longest were the least
likely to be afflicted by these conditions. Such informa-
tion may be valuable in conversations with patients
about clinical decisions such as the continuance of can-
cer screening into age ranges that are not addressed in
clinical practice guidelines, as the usefulness of such
preventive health manoeuvres is affected by the patient’s
expected remaining lifespan. These types of conversations
are becoming increasingly common in Canada with the
rapidly growing senior cohort and the establishment of
cancer screening programmes.
Many of the medications prescribed to patients in this
study were for risk modification. Of the top 10 most
frequently prescribed medication classes overall, only 3
(non-opioid analgesics, proton pump inhibitors, andTable 5 Top 10 most common prescription medication classe
Males Females
Rank Medication class % Medication class
1 Statins 59.8 Analgesics, non-opioid
2 Analgesics, non-opioid 49.8 Bisphosphonates
3 Beta-blockers 42.6 Statins
4 Ace-inhibitors 42.1 Calcium (alone or in com
with Vitamin D)
5 Anti-thrombotic agents 35.9 CCBs
6 PPIs 35.4 Beta-blockers
7 BPH drugs 35.4 Thiazide diuretics (alone
with other drugs)
8 CCBs 31.6 PPIs
9 Drugs for constipation 30.6 Drugs for constipation
10 Thiazide diuretics (alone or in
combination with other drugs)
29.2 Ace-inhibitors
The bolded medications are for symptom relief. PPIs, proton pump inhibitors; BPH ddrugs for constipation) were aimed at symptom relief. A
similar pattern has been documented at the population
level [4].
The extent of this disproportion is made more con-
spicuous by the fact that in an era where scientific
evidence is so often cited to justify medical practice,
there is a total lack of evidence in this age group to
support the efficacy of the risk-modifying medications
that are being prescribed with such frequency.
Furthermore, well-intentioned efforts to extend the
length of life through risk modification may ironically
result in worsening the quality of life in complex elderly
patients. Other authors [13] have written about how pa-
tients can become confused and their daily schedules
overtaken by complicated medication regimens resulting
from the implementation of multiple clinical practice
guidelines which may even contradict each other. Qualitys in patients aged 85+ by sex
Overall
% Medication class %
50.4 Analgesics, non-opioid 50.2
47.3 Statins 47.9
40.8 Beta-blockers 36.7
bination 36.6 Bisphosphonates 34.4
35.5 CCBs 34.0
33.2 PPIs 33.3
or in combination 32.7 Ace-inhibitors 33.3
32.1 Thiazide diuretics (alone or in
combination with other drugs)
31.4
30.4 Drugs for constipation 30.5
28.2 Calcium (alone or in combination
with Vitamin D)
30.3
rugs, benign prostatic hypertrophy drugs; CCBs, calcium channel blockers.
Table 6 Top 10 most common prescription medications by age group
85-89 yrs 90-94 yrs 95+ yrs
Rank Medication % Medication % Medication %
1 Atorvastatin 37.3 Amlodipine 31.2 Amlodipine 31.3
2 ASA (mini) 34.5 Hydrochlorothiazide 30.1 Acetaminophen 31.3
3 Hydrochlorothiazide 28.4 ASA (mini) 29.5 ASA (mini) 28.1
4 Ramipril 26.5 Levothyroxine 29.5 Docusate 28.1
5 Vitamin D 25.4 Ramipril 27.2 Atorvastatin 25.0
6 Warfarin 22.3 Atorvastatin 24.9 Vitamin D 25.0
7 Levothyroxine 20.9 Docusate 24.3 Warfarin 25.0
8 Amlodipine 19.5 Vitamin D 19.1 Metoprolol 25.0
9 Metoprolol 19.2 Alendronate 17.9 Alendronate 21.9
10 Calcium 18.9 Acetaminophen 17.3 Calcium 21.9
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adverse effects, which are more likely in the setting of
polypharmacy [14].
There are some encouraging trends in our data which
illustrate practical responses to the concerns outlined
above. Firstly, while there are no risk-modifying medica-
tions shown to have benefit in this old population, there
are some which may cause harm. These should be used
with great caution. For example, diabetes medications
can cause hypoglycemic episodes in the elderly [15] and
our data indicate that the physicians whose patients we
studied did not prescribe these medications frequently.
Secondly, while there is no evidence directly in the
oldest old for risk-modifying medications, there are
trends in the data from younger age groups which can
be used to inform thoughtful prescribing decisions for their
older counterparts. For example, it has been observed that
the time to benefit [16] for many of these medications is
often measured in years, and thus it is rational to use themTable 7 Top 10 most common prescription medication classe
85-89 yrs 90-94 yrs
Rank Medication class % Medication clas
1 Statins 54.3 Analgesics, non-
2 Analgesics, non-opioid 51.8 CCBs
3 Beta-blockers 37.3 Drugs for constip
4 Ace-inhibitors 34.5 Bisphosphonates
5 PPIs 34.0 Statins
6 Thiazide diuretics (alone or in
combination with other drugs)
32.6 Beta-blockers
7 Bisphosphonates 31.8 Ace-inhibitors
8 Anti-thrombotic Agents 31.5 PPIs




10 CCBs 29.2 Thyroid therapy
replacement or aless often as patients age and have fewer expected years of
life remaining. In our data set, this principle is reflected in
the decreasing use of statin medications with increasing
age and the infrequent use of anti-hyperglycemics.
There was no difference in complexity scores between
age or sex categories, but the overall median score of
12.5 indicates a high level of complexity in this patient
population. This translates into a more than 2-fold poten-
tial increase in hospitalization and emergency department
admissions compared to patients with a complexity score
between 0–5 [9]. Although the mean complexity score in
this patient sample was high, the distribution of scores
was wide (ranging from 2 to 29). This reflects the hetero-
geneous nature of even the oldest old population and
serves as a useful reminder for the clinician that they must
not be viewed through a “one size fits all” lens. The most
complex patients take a large number of medications and
are at high risk for drug interactions, and thus it is even
more difficult to justify further complicating their regimens by age group
95+ yrs
s % Medication class %
opioid 46.2 Analgesics, non-opioid 53.1
43.4 Beta-blockers 40.6
ation 38.7 Bisphosphonates 40.6
38.7 Drugs for constipation 37.5
37.6 CCBs 37.5




32.9 Analgesics, opioids 31.3





30.1 Angiotensin II-antagonists, plain 28.1
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as discussed above. Conversely, there are patients over
85 years old who have low clinical complexity and excel-
lent quality of life who wish to take these medications
even while recognizing the lack of data derived from sub-
jects their age, because there is a chance that they will
benefit and live longer as a result. Such patient preferences
should be respected. In fact, recent guidelines [17]
have made explicit this very idea of a patient-centred
approach to risk modification that accounts for a patient's
clinical status.
The major strength of this study is the large number
of patients 85 years of age and older who were included.
This study is subject to certain limitations. The sample
of patients came from a single primary care unit in an
academic health centre in Toronto, located in an educated
and affluent neighborhood. Each of these traits may have
an influence on the ability to generalize our results to
other seniors over the age of 85. For example, the high
rate of osteoporosis may be due to the fact that in an
academic environment, great emphasis was placed
upon adhering to screening guidelines. It has been shown
elsewhere that poor socioeconomic status (SES) places
one at higher risk for coronary artery disease [18], and
thus the relatively low rate of CAD in our study may be
partially explained by the clinic’s location in a high SES
neighborhood.
The study was also limited because its data was extrac-
ted exclusively from the CPP. Each patient's physician is
responsible for the upkeep of this portion of the patient
chart, and therefore variation in their charting habits
could have influenced our results. For example, the dis-
parity between the prevalence of osteoporosis in females
and prescriptions of calcium and Vitamin D may be due
to the fact that clinicians recommended that their
patients buy these supplements over-the-counter, and
did not record this in their medication list. It is also
likely that we missed chronic conditions which were not
entered in the CPP despite being documented in the
body of patients’ charts.
Conclusions and recommendations
As the aging Canadian population expands and their
burden of health care falls largely on the shoulders of
family physicians, it is becoming ever more important to
understand the health characteristics and medication
profiles of the oldest old. Our study demonstrates that
6.4% of the patients in a family practice are above 85 years
old, and that the majority of documented chronic condi-
tions in this population are related to both cardiovascular
and bone health. The data also highlights the significant
number of medications used on a daily basis by older
adults. This information provides the basis for reflection
on several issues relevant to the clinical care of the oldestold such as the necessity of risk-modifying medications,
the prioritization of quality versus quantity of life, and
the importance of recognizing heterogeneity in this
population.
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